Using a Speech-Generating Device to Support Communication in Childhood Dementia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Individuals with childhood dementia experience loss of developmental skills and many have limited verbal speech. The aim of this clinical trial is to examine how well a speech-generating device supports the communication skills of participants with childhood dementia. The speech-generating device is a communication program loaded onto an iPad. This is a crossover trial, meaning that each participant will receive both the treatment (device) and a control (usual care; no device) phase. The order in which each participant receives the device versus the usual care (no device) will depend on which group the participant is assigned to. The changes in communication in each phase will then be compared. During the trial, participants can expect to complete a series of assessments and attend a total of 2 x 1-hour therapy session per week for 6 weeks.
Epistemonikos ID: 00eb6846715d428d26ccb2199f5674d2d2bcd74a
First added on: Jun 27, 2025